A detailed history of Public Employees Retirement System Of Ohio transactions in Myriad Genetics Inc stock. As of the latest transaction made, Public Employees Retirement System Of Ohio holds 759 shares of MYGN stock, worth $16,667. This represents 0.0% of its overall portfolio holdings.

Number of Shares
759
Previous 771 1.56%
Holding current value
$16,667
Previous $16,000 12.5%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$17.98 - $25.47 $215 - $305
-12 Reduced 1.56%
759 $18,000
Q1 2024

May 15, 2024

SELL
$17.59 - $23.59 $756 - $1,014
-43 Reduced 5.28%
771 $16,000
Q4 2023

Feb 15, 2024

SELL
$13.91 - $21.32 $1,404 - $2,153
-101 Reduced 11.04%
814 $15,000
Q3 2023

Dec 19, 2023

SELL
$15.99 - $23.22 $751 - $1,091
-47 Reduced 4.89%
915 $14,000
Q3 2023

Nov 15, 2023

SELL
$15.99 - $23.22 $751 - $1,091
-47 Reduced 4.89%
915 $15,000
Q2 2023

Dec 19, 2023

SELL
$17.56 - $23.76 $1,791 - $2,423
-102 Reduced 9.59%
962 $22,000
Q2 2023

Aug 15, 2023

SELL
$17.56 - $23.76 $1,791 - $2,423
-102 Reduced 9.59%
962 $22,000
Q1 2023

Dec 19, 2023

SELL
$15.26 - $23.75 $320 - $498
-21 Reduced 1.94%
1,064 $24,000
Q1 2023

May 15, 2023

SELL
$15.26 - $23.75 $320 - $498
-21 Reduced 1.94%
1,064 $25,000
Q4 2022

Dec 19, 2023

BUY
$14.51 - $20.99 $2,466 - $3,568
170 Added 18.58%
1,085 $15,000
Q4 2022

Feb 15, 2023

SELL
$14.51 - $20.99 $37,290 - $53,944
-2,570 Reduced 70.31%
1,085 $16,000
Q3 2022

Nov 15, 2022

SELL
$18.21 - $27.88 $1,074 - $1,644
-59 Reduced 1.59%
3,655 $70,000
Q2 2022

Aug 15, 2022

SELL
$16.45 - $25.88 $5,741 - $9,032
-349 Reduced 8.59%
3,714 $67,000
Q1 2022

May 16, 2022

SELL
$22.67 - $28.01 $2,062 - $2,548
-91 Reduced 2.19%
4,063 $102,000
Q4 2021

Feb 15, 2022

SELL
$24.13 - $32.63 $16,142 - $21,829
-669 Reduced 13.87%
4,154 $115,000
Q3 2021

Nov 15, 2021

SELL
$29.97 - $36.66 $29,790 - $36,440
-994 Reduced 17.09%
4,823 $156,000
Q2 2021

Aug 16, 2021

SELL
$25.39 - $32.61 $5,788 - $7,435
-228 Reduced 3.77%
5,817 $178,000
Q1 2021

May 14, 2021

SELL
$19.92 - $31.6 $6,952 - $11,028
-349 Reduced 5.46%
6,045 $184,000
Q4 2020

Feb 12, 2021

SELL
$12.16 - $19.77 $762,067 - $1.24 Million
-62,670 Reduced 90.74%
6,394 $126,000
Q3 2020

Nov 16, 2020

SELL
$11.25 - $14.75 $1.71 Million - $2.24 Million
-151,762 Reduced 68.72%
69,064 $901,000
Q2 2020

Aug 17, 2020

BUY
$10.69 - $16.49 $59,970 - $92,508
5,610 Added 2.61%
220,826 $2.5 Million
Q1 2020

May 13, 2020

BUY
$9.78 - $29.53 $5,965 - $18,013
610 Added 0.28%
215,216 $3.08 Million
Q4 2019

Feb 14, 2020

BUY
$20.93 - $35.1 $1,590 - $2,667
76 Added 0.04%
214,606 $5.84 Million
Q3 2019

Nov 15, 2019

BUY
$22.08 - $47.08 $9,384 - $20,009
425 Added 0.2%
214,530 $6.14 Million
Q2 2019

Aug 12, 2019

SELL
$22.67 - $35.0 $388,881 - $600,390
-17,154 Reduced 7.42%
214,105 $5.95 Million
Q1 2019

May 15, 2019

BUY
$26.93 - $34.7 $2.88 Million - $3.72 Million
107,126 Added 86.3%
231,259 $7.68 Million
Q4 2018

Feb 15, 2019

SELL
$27.23 - $45.56 $633,533 - $1.06 Million
-23,266 Reduced 15.78%
124,133 $3.61 Million
Q3 2018

Nov 14, 2018

SELL
$37.57 - $50.34 $318,819 - $427,185
-8,486 Reduced 5.44%
147,399 $6.78 Million
Q2 2018

Aug 22, 2018

BUY
$27.75 - $40.17 $291,458 - $421,905
10,503 Added 7.22%
155,885 $5.83 Million
Q1 2018

May 15, 2018

SELL
$28.83 - $41.01 $753,558 - $1.07 Million
-26,138 Reduced 15.24%
145,382 $4.3 Million
Q4 2017

Feb 08, 2018

BUY
$28.45 - $37.14 $822,517 - $1.07 Million
28,911 Added 20.27%
171,520 $5.89 Million
Q3 2017

Nov 20, 2017

SELL
$24.01 - $36.2 $10,252 - $15,457
-427 Reduced 0.3%
142,609 $5.16 Million
Q2 2017

Aug 16, 2017

BUY
N/A
143,036
143,036 $3.7 Million

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.77B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Public Employees Retirement System Of Ohio Portfolio

Follow Public Employees Retirement System Of Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.